Moxifloxacin vs amoxicillin‐clavulanate
SAEs · NSTI
It is very uncertain whether moxifloxacin changes serious adverse events (SAE) compared with amoxicillin‐clavulanate (very low certainty).
1 finding from 1 review
- Interventions for necrotizing soft tissue infections in adults 2018 · Cochrane Headline outcomes onlyRR 0.63 [0.3, 1.31]1 study · 54 participantsVery low